SCHEMBL25872004

SCHEMBL25872004

N#Cc1ccc(-c2cc(-c3ccccc3)c(-c3ccc(-c4nc(-c5ccccc5)nc(-c5cccc(-c6ccccc6)c5)n4)cc3)cc2-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 13/20 0.51
ABCB1 P08183 8/20 0.51
ABCC1 P33527 3/20 0.46
GABRA1 P14867 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
LMNA P02545 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383762 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23384204 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23384206 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23384026 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23383857 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23383899 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23383760 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23383794 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23384198 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2
SCHEMBL23384022 0.94 ABCG2 (0.56) ABCG2ABCB1ABCC1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212141-A1 Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same NOVALED GMBH (DE) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212141-A1 Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same AOX1, ICMT, OCIAD2 ABCG2 3068/4885ABCB1 2820/4885ABCC1 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.